Oxford Biomedica and Beam Therapeutics sign CAR-T deal
The Pharma Data
AUGUST 4, 2020
. UK-based Oxford Biomedica has signed a new development, manufacture and license agreement with Beam Therapeutics for next-generation CAR-T therapeutics. The agreement also puts in place a three year clinical supply agreement for the two companies.
Let's personalize your content